fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptika, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
ponderax dragees
les laboratoires servier - fenfluraminhydrochlorid - dragees - fenfluraminhydrochlorid 20.mg
ponderax retard kapsel
les laboratoires servier - fenfluraminhydrochlorid - kapsel - fenfluraminhydrochlorid 60.mg
realitor retardkapsel
les laboratoires servier - fenfluraminhydrochlorid - retardkapsel - fenfluraminhydrochlorid 60.mg
insulin novonordisk actrapid hm 100 ie/ml injektionslösung
novo nordisk pharma ag - insulinum menschlichen adnr löslich - injektionslösung - insulinum humanum adnr solutum 100 u.i., glycerolum, zincum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
insulin novonordisk insulatard hm 100 ie/ml injektionssuspension
novo nordisk pharma ag - insulinum humanum adnr isophanum - injektionssuspension - insulinum humanum adnr isophanum 100 u.i., protamini sulfas, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 1.5 mg, phenolum 0.65 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - diabetes mellitus - biotechnologika
insulin novonordisk actrapid hm 100 ie/ml penfill 3 injektionslösung
novo nordisk pharma ag - insulinum menschlichen adnr löslich - injektionslösung - insulinum humanum adnr solutum 100 u.i., glycerolum, zincum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabetes mellitus - biotechnologika
insulin novonordisk insulatard hm 100 ie/ml penfill 3 injektionssuspension
novo nordisk pharma ag - insulinum humanum adnr isophanum - injektionssuspension - insulinum humanum adnr isophanum 100 u.i., protamini sulfas, zincum, glycerolum, natrii phosphates, conserv.: metacresolum 1.5 mg, phenolum 0.65 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml. - diabetes mellitus - biotechnologika
insulin lilly huminsulin basal cartouches 3,0 ml injizierbare suspension
eli lilly (suisse) sa - insulinum humanum adnr isophanum - injizierbare suspension - insulinum humanum adnr isophanum 100 u.i., metacresolum, glycerolum, phenolum, protamini sulfas, dinatrii phosphas heptahydricus, zinci oxidum, acidum hydrochloridum dilutum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.6 mg. - diabetes mellitus - biotechnologika
insulin lilly humalog flacon injizierbare lösung
eli lilly (suisse) sa - insulinum lisprum - injizierbare lösung - insulinum lisprum 100 u.i. corresp. insulinum lisprum 3.5 mg, glycerolum, zinci oxidum, dinatrii phosphas heptahydricus, metacresolum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.5 mg. - diabetes mellitus - biotechnologika